Biopharmaceutical profile of cerivastatin, a novel HMG-CoA reductase inhibitor

被引:5
|
作者
Muck, W
Ochmann, K
Mazzu, A
Lettieri, J
机构
[1] BAYER AG,CLIN PHARMACOL,D-5600 WUPPERTAL,GERMANY
[2] BAYER CORP,CLIN PHARMACOL,W HAVEN,CT
关键词
D O I
10.1016/S0021-9150(97)88701-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:130 / 130
页数:1
相关论文
共 50 条
  • [41] Newer HMG-CoA reductase inhibitor (statin) therapies
    Brinton, EA
    CLINICAL CARDIOLOGY, 2001, 24 (07) : II10 - II13
  • [42] Photochemical activity of glenvastatin, a HMG-CoA reductase inhibitor
    Sobotta, L.
    Kachlicki, P.
    Marczak, L.
    Kryjewski, M.
    Mielcarek, J.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2011, 224 (01) : 1 - 7
  • [43] HYPERKALEMIA DURING TREATMENT WITH HMG-COA REDUCTASE INHIBITOR
    EDELMAN, S
    WITZTUM, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18): : 1219 - 1220
  • [44] PRAVASTATIN SODIUM, A NEW HMG-COA REDUCTASE INHIBITOR
    RAASCH, RH
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (04): : 388 - 394
  • [45] INHIBITION OF CHOLESTEROL ABSORPTION BY HMG-COA REDUCTASE INHIBITOR
    MIETTINEN, TA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S19 - S21
  • [46] Rosuvastatin - A new HMG-CoA reductase inhibitor for hypercholesterolemia
    Roach, AE
    Tsikouris, JP
    Haase, KK
    FORMULARY, 2002, 37 (04) : 179 - +
  • [47] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Pak, Valeriy V.
    Kwon, Dae Yong
    Khojimatov, Olim K.
    Pak, Aleksandr, V
    Sagdullaev, Shomansur Sh
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1923 - 1931
  • [48] HMG-CoA reductase inhibitor treatment in renal insufficiency
    Wanner, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (10) : 1951 - 1952
  • [49] TOWARDS A NEW TYPE OF HMG-COA REDUCTASE INHIBITOR
    BARTH, M
    BELLAMY, FD
    RENAUT, P
    SAMRETH, S
    SCHUBER, F
    TETRAHEDRON, 1990, 46 (19) : 6731 - 6740
  • [50] HMG-CoA reductase inhibitor-induced impotence
    Halkin, A
    Lossos, IS
    Mevorach, D
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (02) : 192 - 192